Chapter-by-chapter discussion, covering:<ul><li>opium/ heroin</li><li>antibiotics</li><li>contraceptive pill</li><li>vaccines</li><li>and more...</li></ul>Find more by Thomas Hager here: https://www.thomashager.net

Chapter-by-chapter discussion, covering:opium/ heroinantibioticscontraceptive pillvaccinesand more...Find more by Thomas Hager here: https://www.thomashager.net

Chapter-by-chapter discussion, covering:<ul><li>opium/ heroin</li><li>antibiotics</li><li>contraceptive pill</li><li>vaccines</li><li>and more...</li></ul>Find more by Thomas Hager here: https://www.thomashager.net&nbsp;

IDEA Collider | Pharma Book Club | Thomas Hager

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.

Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.

Questions We Explore

* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?


🎧 Listen and subscribe on all major platforms.

Business

Science

Marketing

Management

Life Sciences

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking. Questions We Explore * What is asymmetric learning, and how does it fuel pharma innovation? * Why do some organizations outpace others—and what can we learn from them? * How can we overcome barriers to meaningful progress in healthcare? * What’s broken in traditional innovation models—and how do we fix it? 🎧 Listen and subscribe on all major platforms.

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma &amp; Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.

Each episode dives into how organizations can make smarter decisions earlier, reimagine R&amp;D, and unlock competitive advantage through differentiated thinking.

Questions We Explore

* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?


🎧 Listen and subscribe on all major platforms.

Share IDEA Collider | Pharma Book Club | Thomas Hager

Sign up to save your podcasts

IDEA Collider | Pharma Book Club | Thomas Hager

IDEA Collider | Pharma Book Club | Thomas Hager